COLUMBUS, Ohio–(BUSINESS WIRE)–Forge Biologics, a gene therapy-focused contract growth and manufacturing group, introduced in the present day the addition of three key management hires to additional the Firm’s development as a number one producer of genetic medicines.
“Our group has constructed one of many largest genetic medicines manufacturing amenities on this planet, with the flexibility for end-to-end AAV manufacturing of 50L to five,000L,” stated Timothy J. Miller, Ph.D., CEO, President, and Co-Founding father of Forge. “Increasing our management group with these strategic hires, and the caliber of expertise every member brings, helps our imaginative and prescient for development and the worth we offer to our greater than 30 companions as we proceed to develop our management in gene remedy growth and manufacturing. I’m delighted to welcome Mr. McPherson and Ms. Barsoumian, and congratulate Dr. Davis on his new function.”
Chris McPherson, Vice President of GMP Manufacturing
Chris McPherson will oversee medical and industrial cGMP manufacturing operations of Forge’s 50L to five,000L bioreactors in 20 cGMP suites. Mr. McPherson joins Forge with over 25 years of business expertise in industrial biologics manufacturing, expertise switch, validation and BLA/MAA preparation, bringing his experience in steady enchancment for effectivity and compliance, downside fixing, and scale up of consumer processes in a contract manufacturing setting. Previous to becoming a member of Forge, Mr. McPherson helped to scale processes and full the expertise switch from 20L to fifteen,000L of biologics manufacturing. He’s held technical management positions in business as Director of Manufacturing, Principal Scientist for Validation, Audits, and Inspections and Head of Scientific Manufacturing with Guilford Pharmaceutical, Cambrex Bioscience, WuXi Apptec, Biotest Pharmaceutical and Samsung Biologics. Mr. McPherson’s two B.S. levels are in Chemistry and Biochemistry from Pennsylvania State College.
Taleen Barsoumian, Vice President of Consumer Improvement
Taleen Barsoumian will lead Forge’s consumer growth technique and new enterprise operations throughout Forge’s suite of producing options. Ms. Barsoumian was beforehand the U.S. Director of Gross sales and Enterprise Improvement for Cell and Gene at Barkey Company, and brings 18 years of expertise working with companions in academia, biotech, pharma, authorities and diagnostics. Previous to becoming a member of Barkey, she was the BioScience Western Regional Gross sales Supervisor for North America at Greiner Bio-One, following seven years with Novartis Prescribed drugs, the place she was Senior Cardiovascular Gross sales Advisor. Ms. Barsoumian earned her B.S. in Epidemiology from the Keck Faculty of Drugs on the College of Southern California.
Adam Davis, Ph.D., Vice President of Analytical Improvement
Adam Davis leads the in-house analytical growth and testing group supporting purchasers all through product growth and manufacturing. Dr. Davis joined Forge in 2020 after 15 years of expertise in recombinant adeno-associated viral (AAV) vector product growth, course of growth, and manufacturing. His groups lead the phase-appropriate growth, qualification and validation of analytics to help the manufacturing of pre-clinical and medical recombinant gene remedy vectors. Previous to becoming a member of Forge, Dr. Davis was the Director of Manufacturing at Abeona Therapeutics, he held the place of Manufacturing Scientist at BioMarin Prescribed drugs, and accomplished his post-doctoral work in gene remedy growth and manufacturing at Nationwide Kids’s Hospital. He earned his Ph.D. from The Ohio State College, specializing in the rational design of recombinant AAV vector capsid for focused supply.
About Forge Biologics
Forge Biologics is a hybrid gene remedy contract manufacturing and clinical-stage therapeutics growth firm. Forge’s mission is to allow entry to life-changing gene therapies and assist convey them from concept to actuality. Forge’s 200,000 sq. foot facility makes use of 20 cGMP suites in Columbus, Ohio, the Fireside, to function its headquarters. The Fireside is a custom-designed cGMP facility largely devoted to AAV manufacturing and hosts scalable, end-to-end manufacturing companies. Choices embody course of and analytical growth, plasmid DNA manufacturing, viral vector manufacturing, last fill, in addition to regulatory consulting help to speed up gene remedy applications from preclinical by way of medical and industrial stage manufacturing. By taking a patients-first strategy, Forge goals to speed up the timelines of those transformative medicines for many who want them probably the most. To be taught extra, go to www.forgebiologics.com.
